pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
425
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
Gliflozins
Congestive Heart Failure (Heart Failure)
$RTX
RTX Corp
Preclinical
Glunozumab
Unspecified
Lys Therapeutics SAS
Preclinical
Granulocyte Colony-Stimulating-Factor (G-CSF)
Thromboangiitis obliterans (Buerger disease)
Vasogenesis Inc
Phase 2
← prev
page 6 of 15
next →
Pain
89
Neurology
1
HBI-3000
Atrial Fibrillation
HUYA Bioscience International LLC
Phase 2
HUNS-001
Cerebral Infarction (Brain Infarction)
Rainbow Inc
Preclinical
HY-074
Acute Coronary Syndrome
Hyloris Pharmaceuticals SA
Preclinical
HY-075
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hyloris Pharmaceuticals SA
Phase 2
HeXell-2020
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hexun Bioscience Co Ltd
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
Marketed
Intropin
Dopamine Hydrochloride
Hemorrhagic Shock
$PFE
PFIZER INC
Preclinical
JBTmiR-2
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Jaan Biotherapeutics Inc
Phase 2
JK-07
Diastolic Heart Failure (HFpEF)
Salubris Biotherapeutics Inc
Preclinical
K-130
Neurogenic Orthostatic Hypotension (nOH)
$AMRX
Amneal Pharmaceuticals, Inc.
Phase 3
KPL-387
Pericarditis
$KNSA
Kiniksa Pharmaceuticals International, plc
Phase 2
LX-2006
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
Phase 2
LX-2020
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
Marketed
Lotensin HCT
Benazepril Hydrochloride + Hydrochlorothiazide + Rising ((benazepril hydrochloride + hydrochlorothiazide [INN]))
Hypertension
Rising Pharma Holdings Inc
Preclinical
M-9i
Acute Ischemic Stroke
Translational Sciences Inc
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
Marketed
Micardis HCT
Micardis HCT ((hydrochlorothiazide [INN] + telmisartan))
Hypertension
Boehringer Ingelheim Corp
Phase 2
Motrem
Septic Shock
Inotrem SA
Phase 2
Mydicar
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
Preclinical
NIV-001
Stroke
Neuro-Innovators LLC
Preclinical
NOVS-100
Obesity
Celloram Inc
Preclinical
NP-6A
Cardiomyopathy
Novopyxis Inc
Phase 1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
